Selection of samples for Incurred Sample Reanalysis [Regulatives / Guidelines]

posted by Ken Peh – Malaysia, 2014-05-22 21:42 (4414 d 05:05 ago) – Posting: # 12991
Views: 4,144

Dear All,

EMEA guideline mentions that "10% of the samples should be reanalysed in case the number of samples is less than 1000 samples and 5% of the number of samples exceeding 1000 samples. Furthermore, it is advised to obtain samples around Cmax and in the elimination phase".

I would be glad to have your feedback and comments on the following questions:
  1. Do we have to take the samples of each and every subjects or it is sufficient as long as we can fulfill the no of samples required ? What is the right approach ? :confused:
  2. It is advised to obtain samples around Cmax and in the elimination phase. Does it mean that around Cmax is at the absorption phase before Cmax ?
Your feedback is highly appreciated.

Thank you.

Regards,
Ken

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
148 visitors (0 registered, 148 guests [including 59 identified bots]).
Forum time: 02:48 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5